series-a
Stage
1
Investors
About
MyoKardia develops targeted therapies for serious cardiovascular diseases, with a focus on treating genetic heart conditions.
Explore MyoKardia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.